Corrigendum to "Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab".
Thi Ha Chau TranStéphane DumasFlorence CoscasPublished in: Journal of ophthalmology (2018)
[This corrects the article DOI: 10.1155/2017/8984313.].